Sam+Leo LLC – Trademark Portfolio

Entity Type: 16

Sam+Leo LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SAM+LEO and SAM + LEO. The owner is based in Aspen, CO.

1501 Maroon Creek Rd, Unit 2

Aspen, CO 81611

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SAM+LEO
SAM+LEO
Registered 2022
GRAYCLAY
GRAYCLAY
Abandoned 2020
SAM + LEO
SAM + LEO
Registered 2020

Trademark Classifications

Sam+Leo LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does Sam+Leo LLC have?

Sam+Leo LLC has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.

What trademark classes does Sam+Leo LLC file in?

Sam+Leo LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Sam+Leo LLC's most well-known trademarks?

Sam+Leo LLC's registered trademark portfolio includes well-known marks such as SAM+LEO and SAM + LEO. These are among 2 currently registered trademarks in the portfolio.

What is Sam+Leo LLC's trademark registration success rate?

Sam+Leo LLC has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.